This activity is planned for AMA PRA Category 1 Credit(s)™. Further information will be available at the end of 2010.

 

Who should attend?

The 14th World Conference on Lung Cancer will be one of the largest international gatherings of clinicians and scientists in the lung cancer field. Those interested in all aspects of lung cancer including surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, nuclear medicine physicians, basic research scientists, nurses and allied health professionals are encouraged to attend this conference.

 

Official Language

The official language of the 14th World Conference on Lung Cancer is English.

 

Programme Objectives

At the 14th World conference on Lung Cancer, our objectives are to:

• Share and discuss recent advances in prevention, imaging, early detection and treatment of lung cancer
• Review advances in the molecular biology, pharmacogenomics and monitoring effects of treatment of lung cancer and how these apply to personalized medicine
• Discuss tobacco control methods being utilized throughout the world
• Evaluate results from recent clinical trials related to lung cancer and mesothelioma
• Review palliative care options for patients with lung cancer
• Support the career development of fellows and junior faculty with an interest in lung cancer
• Review the role of nurses in (multidisciplinary) patient care and clinical research as well as educate nurses on new aspects of care for patients with lung cancer

 

Programme Topics

The 14th World Conference on Lung Cancer will highlight recent important advances in lung cancer in the areas of prevention, early detection, molecular biology, biotechnology and therapy.